VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $253,000 | -34.3% | 53,800 | 0.0% | 0.00% | – |
| Q4 2020 | $385,000 | -32.9% | 53,800 | 0.0% | 0.00% | – |
| Q3 2020 | $574,000 | -15.5% | 53,800 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $679,000 | +40.0% | 53,800 | +1.5% | 0.00% | 0.0% |
| Q1 2020 | $485,000 | -34.4% | 53,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $739,000 | -17.1% | 53,000 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $891,000 | -28.1% | 51,800 | +13.8% | 0.00% | 0.0% |
| Q2 2019 | $1,239,000 | +83.3% | 45,500 | +28.9% | 0.00% | 0.0% |
| Q1 2019 | $676,000 | +103.6% | 35,300 | 0.0% | 0.00% | – |
| Q4 2018 | $332,000 | -50.3% | 35,300 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $668,000 | -3.2% | 35,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $690,000 | +25.0% | 35,300 | +20.1% | 0.00% | 0.0% |
| Q1 2018 | $552,000 | +13.1% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $488,000 | – | 29,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |